Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00142220Phase 4Completed
Phase 4, randomised trial of omega-3 fatty acid in sepsis (2 arms), sponsored by Universitätsklinikum Greifswald. Primary endpoints: Interleukin-6 level in serum and HLA-expression on monocytes. Started Jan 2004; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00142220.